Skip Navigation LinksVaccine Adverse Event Reporting System. The image includes photgraphs of a couple, a doctor, a women and child, a baby, and an elderly.
     

CDC

Food and Drug Administration (FDA)

Introduction

Frequently Asked Questions

Bibliography

Contact Information

VAERS Form
(PDF 23K)

VAERS Web Submission

VAERS Data

VAERS Continuing Education

Publications

Links

Privacy Policies & Disclaimers

Call VAERS at
1-800-822-7967

VAERS Bibliography - May 2004

  1. Unlicensed Flu Vaccine Reported in USA. S.Afr.Med.J. 94 (3): 158-159; March, 2004.

  2. Measles Outbreak in a Boarding School--Pennsylvania, 2003. MMWR Morb.Mortal.Wkly.Rep. 53 (14): 306-309; April 16, 2004.

  3. Progress Toward Measles Elimination--Region of the Americas, 2002-2003. MMWR Morb.Mortal.Wkly.Rep. 53 (14): 304-306; April 16, 2004.

  4. Aaby, P.; Jensen, H.; Rodrigues, A.; Garly, M. L.; Benn, C. S.; Lisse, I. M.; Simondon, F. Divergent Female-Male Mortality Ratios Associated With Different Routine Vaccinations Among Female-Male Twin Pairs. Int.J.Epidemiol. 33 (2): 367-373; April, 2004.

  5. Ahmad, K. Vaccination Halts Meningitis Outbreak in Burkina Faso. Lancet. 363 (9417): 1290; April 17, 2004.

  6. Aldrete, J. A. Smallpox Vaccination in the Early 19th Century Using Live Carriers: the Travels of Francisco Xavier De Balmis. South.Med.J. 97 (4): 375-378; April, 2004.

  7. Aylward, R. B.; Cochi, S. L. Framework for Evaluating the Risks of Paralytic Poliomyelitis After Global Interruption of Wild Poliovirus Transmission. Bull.World Health Organ. 82 (1): 40-46; January, 2004.

  8. Balkhy, H. H.; Memish, Z. A.; Bafaqeer, S.; Almuneef, M. A. Influenza a Common Viral Infection Among Hajj Pilgrims: Time for Routine Surveillance and Vaccination. J.Travel.Med. 11 (2): 82-86; March, 2004.

  9. Barouni, A. S.; Augusto, C.; Queiroz, M. V.; Lopes, M. T.; Zanini, M. S.; Salas, C. E. BCG Lymphadenopathy Detected in a BCG-Vaccinated Infant. Braz.J.Med.Biol.Res. 37 (5): 697-700; May, 2004.

  10. Blanco, Quiros A.; Gimenez, Sanchez F.; Asensi, Botet F.; Bernaola, Iturbe E.; De Juan, Martin F.; Garcia, Perez J.; Garces, Sanchez M.; Gomez Campdera, J. A.; Picazo, J. J.; Pineda, Solas, V  [Vaccination Schedule of the Spanish Association of Pediatrics. Recommendations 2004]. An.Pediatr.(Barc.). 60 (5): 468-472; May, 2004.

  11. Blasiole, D. A.; Metzgar, D.; Daum, L. T.; Ryan, M. A.; Wu, J.; Wills, C.; Le, C. T.; Freed, N. E.; Hansen, C. J.; Gray, G. C.; Russell, K. L. Molecular Analysis of Adenovirus Isolates From Vaccinated and Unvaccinated Young Adults. J.Clin.Microbiol. 42 (4): 1686-1693; April, 2004.

  12. Bredin, C. P. Tuberculosis in the Ireland of 2003: It Hasn't Gone Away. Ir.Med.J. 97 (1): 6-7; January, 2004.

  13. Breeze, E.; Mangtani, P.; Price, G. M.; Kovats, S.; Roberts, J.; Fletcher, A. E. Trends in Influenza Vaccination Uptake Among People Aged Over 74 Years, 1997-2000: Survey of 73 General Practices in Britain. BMC.Fam.Pract. 5 (1): 8; April, 2004.

  14. Brydak, L. B.; Machala, M.; LAguna, P.; Rokicka-Milewska, R. Antibody Response to Influenza Vaccination in Splenectomized Patients in Poland. J.Clin.Immunol. 24 (3): 225-236; May, 2004.

  15. Check, E. Side Effects Leave Smallpox Vaccine in Limbo. Nature. 428 (6985): 789; April 22, 2004.

  16. Chi, R. C.; Neuzil, K. M. The Association of Sociodemographic Factors and Patient Attitudes on Influenza Vaccination Rates in Older Persons. Am.J.Med.Sci. 327 (3): 113-117; March, 2004.

  17. Chodaczek, G. [Adjuvants As Factors Improving Efficiency of Vaccination]. Postepy Hig.Med.Dosw. 58:47-59; March 2, 2004.

  18. Chong, C. Y.; Lim, S. H.; Ng, W. Y.; Tee, N.; Lin, R. V. Varicella Screening and Vaccination for Healthcare Workers at KK Women's and Children's Hospital. Ann.Acad.Med.Singapore. 33 (2): 243-247; March, 2004.

  19. Dine, M. S.; Hutchins, S. S.; Thomas, A.; Williams, I.; Bellini, W. J.; Redd, S. C. Persistence of Vaccine-Induced Antibody to Measles 26-33 Years After Vaccination. J.Infect.Dis. 189 Suppl 1:123-30; May 1, 2004.

  20. Dixon-Woods, M.; Brown, H.; Arthur, A.; Matthews, R.; Jagger, C. Organising Services for Influenza Vaccination for Older People. J.Health Serv.Res.Policy. 9 (2): 85-90; April, 2004.

  21. Everett, W. W.; Zaoutis, T. L.; Halpern, S. D.; Strom, B. L.; Coffin, S. E. Preevent Vaccination Against Smallpox: a Survey of Pediatric Emergency Health Care Providers. Pediatr.Infect.Dis.J. 23 (4): 332-337; April, 2004.

  22. Fine, M. The Rhode Island Influenza Vaccine Experience 1995-2003: Influenza Vaccine Price, Reimbursement, Availability, and Rhode Island's Influenza Vaccination Rate. Med.Health R.I. 87 (3): 79-80; March, 2004.

  23. Fine, M. The Rhode Island Adult Vaccination Experience 1995-2003: Public Health, Marketplace Values, and Lessons Learned About the Integrity of Medicine As a Profession. Med.Health R.I. 87 (3): 75-76; March, 2004.

  24. Fontanesi, J.; Shefer, A. M.; Fishbein, D. B.; Bennett, N. M.; De Guire, M.; Kopald, D.; Holcomb, K.; Stryker, D. W.; Coleman, M. S.  Operational Conditions Affecting the Vaccination of Older Adults. Am.J.Prev.Med. 26 (4): 265-270; May, 2004.

  25. Ford, E. S.; Williams, S. G.; Mannino, D. M.; Redd, S. C. Influenza Vaccination Coverage Among Adults With Asthma: Findings From the 2000 Behavioral Risk Factor Surveillance System. Am.J.Med. 116 (8): 555-558; April 15, 2004.

  26. Frederiksen, M. S.; Brenoe, E.; Trier, J. Erythema Multiforme Minor Following Vaccination With Paediatric Vaccines. Scand.J.Infect.Dis. 36 (2): 154-155; 2004.

  27. Freed, G. L. Criteria for Choosing a Specific Vaccine. Arch.Pediatr.Adolesc.Med. 158 (4): 311; April, 2004.

  28. Fringuelli, E.; Lepri, E.; Camilloni, B.; Neri, M.; Carrio, E.; Russano, A.; Spinozzi, F.; Iorio, A. M. Flow Cytometric Measurement of Intracellular IFN-Gamma Induction in Aged Subjects Before and After Parenteral Influenza Vaccination. Dev.Biol.(Basel). 115:55-9; 2003.

  29. Fuessl, H. S. [How Do We Deal With Tick Bites--Vaccination--Antibiotica--Immunotherapy?]. MMW.Fortschr.Med. 145 (15): 35; April 10, 2003.

  30. Gillet, A. M. [Is It Necessary to Vaccinate Against Variola?]. Med.Trop.(Mars.). 63 (6): 643-648; 2003.

  31. Gowda, R.; Cartwright, K.; Bremner, J. A.; Green, S. T. Yellow Fever Vaccine: a Successful Vaccination of an Immunocompromised Patient. Eur.J.Haematol. 72 (4): 299-301; April, 2004.

  32. Grondin, M. A.; Gerbaud, L.; Taillandier, S.; Jalenques, I.; Glanddier, P. Y. [Measurement of the Prevention Policy in the Hospital]. Presse Med. 33 (6): 373-377; March 27, 2004.

  33. Gupta, V.; Bandyopadhyay, S.; Bapuraj, J. R.; Gupta, A. Bilateral Optic Neuritis Complicating Rabies Vaccination. Retina. 24 (1): 179-181; February, 2004.

  34. Gurfinkel, E. P.; de la Fuente, R. L. Two-Year Follow-Up of the FLU Vaccination Acute Coronary Syndromes (FLUVACS) Registry. Tex.Heart Inst.J. 31 (1): 28-32; 2004.

  35. Hanania, N. A.; Sockrider, M.; Castro, M.; Holbrook, J. T.; Tonascia, J.; Wise, R.; Atmar, R. L. Immune Response to Influenza Vaccination in Children and Adults With Asthma: Effect of Corticosteroid Therapy. J.Allergy Clin.Immunol. 113 (4): 717-724; April, 2004.

  36. Hanna, J. N.; Morgan, A. K.; McCulloch, B. G. Uptake of Influenza Vaccine Among Aboriginal and Torres Strait Island Adults in North Queensland, 2003. Commun.Dis.Intell. 28 (1): 80-82; 2004.

  37. Hempstead, K.; Bresnitz, E.; Howell-White, S.; Crabtree, D.; Scotto, Rosato N. Use of a State Regulation for Adult Vaccination. Am.J.Prev.Med. 26 (4): 311-314; May, 2004.

  38. Heymann, D. L. Polio Eradication: Finishing the Job and Protecting the Investment. Bull.World Health Organ. 82 (1): 1; January, 2004.

  39. Hussain, R.; Shahid, F.; Zafar, S.; Dojki, M.; Dockrell, H. M. Immune Profiling of Leprosy and Tuberculosis Patients to 15-Mer Peptides of Mycobacterium Leprae and M. Tuberculosis GroES in a BCG Vaccinated Area: Implications for Development of Vaccine and Diagnostic Reagents. Immunology. 111 (4): 462-471; April, 2004.

  40. Hutchins, S. S.; Baughman, A. L.; Orr, M.; Haley, C.; Hadler, S. Vaccination Levels Associated With Lack of Measles Transmission Among Preschool-Aged Populations in the United States, 1989-1991. J.Infect.Dis. 189 Suppl 1:108-15; May 1, 2004.

  41. Hviid, A.; Stellfeld, M.; Wohlfahrt, J.; Melbye, M. Childhood Vaccination and Type 1 Diabetes. N.Engl.J.Med. 350 (14): 1398-1404; April 1, 2004.

  42. Inoue, T.; Hayashi, N.; Tsuda, K. [Improvement of Tuberculin Test Results With BCG Vaccination in Set-City Primary School Children From 2000 to 2002]. Nippon Koshu Eisei Zasshi. 51 (2): 103-108; February, 2004.

  43. Ipp, M.; Cohen, E.; Goldbach, M.; Macarthur, C. Effect of Choice of Measles-Mumps-Rubella Vaccine on Immediate Vaccination Pain in Infants. Arch.Pediatr.Adolesc.Med. 158 (4): 323-326; April, 2004.

  44. Jee, Y. M.; Cheon, D. S.; Kim, K. S.; Lee, S. H.; Yoon, J. D.; Lee, S. W.; Go, U.; Yang, B. K.; Ki, M. R.; Choi, B. Y.; Cho, H. W. A Seroprevalence Study of Poliovirus Antibody Among Primary Schoolchildren in Korea. Epidemiol.Infect. 132 (2): 351-355; April, 2004.

  45. Kelly, H.; Worth, L.; Karapanagiotidis, T.; Riddell, M. Interruption of Rubella Virus Transmission in Australia May Require Vaccination of Adult Males: Evidence From a Victorian Sero-Survey. Commun.Dis.Intell. 28 (1): 69-73; 2004.

  46. Krueger, M.; Fluegge, K.; Krause, M. F.; Berner, R. Fatal Haemophilus Influenzaetype b Sepsis in a 10-Month-Old Infant Despite Complete Vaccination and Adequate Hib Antibodies. Eur.J.Pediatr. April 15, 2004. [Epub ahead of print].

  47. Kulkarni, V.; Nadgir, D.; Tapiawala, S.; Malabari, A.; Kalgikar, A.; Kela, R.; Nadkar, M.; Kamath, S.; Shah, A. Biphasic Demyelination of the Nervous System Following Anti-Rabies Vaccination. Neurol.India. 52 (1): 106-108; March, 2004.

  48. Langue, J.; Matisse, N.; Pacoret, P.; Undreiner, F.; Boisnard, F.; Soubeyrand, B. Persistence of Antibodies at 5-6 Years of Age for Children Who Had Received a Primary Series Vaccination With a Pentavalent Whole-Cell Pertussis Vaccine and a First Booster With a Pentavalent Acellular Pertussis Vaccine: Immunogenicity and Tolerance of Second Booster With a Tetravalent Acellular Vaccine at 5-6 Years of Age. Vaccine. 22 (11-12): 1406-1414; March 29, 2004.

  49. Letonturier, D. [Influenza Can Hide Other Infections]. Soins.Gerontol. (46): 42-45; March, 2004.

  50. Mallet, E.; Matisse, N.; Mathieu, N.; Langue, J.; Boisnard, F.; Soubeyrand, B. Antibody Persistence Against Diphtheria, Tetanus, Pertussis, Poliomyelitis and Haemophilus Influenzae Type b (Hib) in 5-6-Year-Old Children After Primary Vaccination and First Booster With a Pentavalent Combined Acellular Pertussis Vaccine: Immunogenicity and Tolerance of a Tetravalent Combined Acellular Pertussis Vaccine Given As a Second Booster. Vaccine. 22 (11-12): 1415-1422; March 29, 2004.

  51. March, J. B. DNA Vaccination - Research Tool or a Practical Reality? Expert.Rev.Vaccines. 3 (2): 113-117; April, 2004.

  52. McLaughlin, M. A. Thoughts on Rabies Vaccination Enforcement. J.Am.Vet.Med.Assoc. 224 (6): 834-835; March 15, 2004.

  53. Micco, E.; Gurmankin, A. D.; Armstrong, K. Differential Willingness to Undergo Smallpox Vaccination Among African-American and White Individuals. J.Gen.Intern.Med. 19 (5 Pt 1): 451-455; May, 2004.

  54. Morgan, O. W.; Meltzer, M.; Muir, D.; Hogan, H.; Seng, C.; Hill, J.; Beckford, J. Specialist Vaccination Advice and Pockets of Resistance to MMR Vaccination: Lessons From an Outbreak of Measles. Commun.Dis.Public Health. 6 (4): 330-333; December, 2003.

  55. Mullooly, J. P.; Maher, J. E.; Drew, L.; Schuler, R.; Hu, W. Evaluation of the Impact of an HMO's Varicella Vaccination Program on Incidence of Varicella. Vaccine. 22 (11-12): 1480-1485; March 29, 2004.

  56. Nolan, P. The Rhode Island Meningitis Vaccine Experience--Mass Vaccination Campaigns, Politics and Health Policy. Med.Health R.I. 87 (3): 65-67; March, 2004.

  57. Nookala, S.; Srinivasan, S.; Kaliraj, P.; Narayanan, R. B.; Nutman, T. B. Impairment of Tetanus-Specific Cellular and Humoral Responses Following Tetanus Vaccination in Human Lymphatic Filariasis. Infect.Immun. 72 (5): 2598-2604; May, 2004.

  58. Parlato, A.; Marinelli, A.; Alfieri, R.; Albano, L.; Liguori, G. [The Tetanus in Italy and in the Campania Region: Retrospective Analysis. The Importance of Vaccinations]. Ig Sanita Pubbl. 59 (6): 383-392; November, 2003.

  59. Parve, J. Remove Vaccination Barriers for Children 12 to 24 Months. Nurse Pract. 29 (4): 35-38; April, 2004.

  60. Pazdiora, P.; Januska, J. [Dynamics of Antibody Formation After Vaccination Against Tick-Borne Encephalitis]. Epidemiol.Mikrobiol.Imunol. 53 (1): 17-21; February, 2004.

  61. Redd, S. C.; King, G. E.; Heath, J. L.; Forghani, B.; Bellini, W. J.; Markowitz, L. E. Comparison of Vaccination With Measles-Mumps-Rubella Vaccine at 9, 12, and 15 Months of Age. J.Infect.Dis. 189 Suppl 1:116-22; May 1, 2004.

  62. Rosen, J. B.; Breman, J. G. Malaria Intermittent Preventive Treatment in Infants, Chemoprophylaxis, and Childhood Vaccinations. Lancet. 363 (9418): 1386-1388; April 24, 2004.

  63. Santibanez, T. A.; Zimmerman, R. K.; Nowalk, M. P.; Jewell, I. K.; Bardella, I. J. Physician Attitudes and Beliefs Associated With Patient Pneumococcal Polysaccharide Vaccination Status. Ann.Fam.Med. 2 (1): 41-48; January, 2004.

  64. Singleton, J. A.; Wortley, P.; Lu, P. J. Influenza Vaccination of Persons With Cardiovascular Disease in the United States. Tex.Heart Inst.J. 31 (1): 22-27; 2004.

  65. Spoulou, V.; Giannaki, M.; Vounatsou, M.; Bakoula, C.; Grafakos, S. Long-Term Immunity to Measles, Mumps and Rubella After MMR Vaccination Among Children With Bone Marrow Transplants. Bone Marrow Transplant. April 12, 2004. [Epub ahead of print].

  66. Staines, D. R. Is Osteoporosis Linked to Vaccinations and Gulf War Syndrome? Med.Hypotheses. 62 (5): 670-673; 2004.

  67. Uiterwyk, S. H. Pneumococcal Vaccine: to Vaccinate or to Revaccinate--That Is the Question. Med.Health R.I. 87 (3): 68-71; March, 2004.

  68. Valdmanis, V.; Walker, D.; Fox-Rushby, J. Are Vaccination Sites in Bangladesh Scale Efficient? Int.J.Technol.Assess.Health Care. 19 (4): 692-697; 2003.

  69. Wagenpfeil, S.; Neiss, A.; Banz, K.; Wutzler, P. Empirical Data on the Varicella Situation in Germany for Vaccination Decisions. Clin.Microbiol.Infect. 10 (5): 425-430; May, 2004.

  70. Wakefield, A. J.; Harvey, P.; Linnell, J. MMR--Responding to Retraction. Lancet. 363 (9417): 1327-1328; April 17, 2004.

  71. Zhou, F.; Reef, S.; Massoudi, M.; Papania, M. J.; Yusuf, H. R.; Bardenheier, B.; Zimmerman, L.; McCauley, M. M. An Economic Analysis of the Current Universal 2-Dose Measles-Mumps-Rubella Vaccination Program in the United States. J.Infect.Dis. 189 Suppl 1:131-45; May 1, 2004.

  72. Zielinski, A.; Rosinska, M.; Czarkowski, M.; Rudowska, J. The Effectiveness of Vaccination With Whole-Cell Pertussis Vaccine by Age Group in Poland 1996-2001. Scand.J.Infect.Dis. 36 (2): 114-118; 2004.

Back to Top